Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV000677611 | SCV000803128 | likely pathogenic | Mucopolysaccharidosis type 6 | 2018-01-01 | criteria provided, single submitter | curation | Nonsense variant (PVS1); Very low frequency in ExAC (PM2) |
Foundation for Research in Genetics and Endocrinology, |
RCV000677611 | SCV002822857 | pathogenic | Mucopolysaccharidosis type 6 | 2023-01-16 | criteria provided, single submitter | clinical testing | A Homozygous missense variation in exon 5 of the PIGA gene that results in the termination of amino acid chain at codon 315 was detected. The observed variant c.943C>T (p.Arg315Ter) has not been reported in the 1000 genomes and has MAF of 0.0004% in the gnomAD database. The in silico prediction of the variant are possibly damaging by CADD, DANN, LRT and MutationTaster2. In summary, the variant meets our criteria to be classified as pathogenic. |
Labcorp Genetics |
RCV000677611 | SCV003525877 | pathogenic | Mucopolysaccharidosis type 6 | 2023-11-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg315*) in the ARSB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSB are known to be pathogenic (PMID: 17458871, 22133300). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 20143913, 24875751). ClinVar contains an entry for this variant (Variation ID: 559828). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000677611 | SCV004209825 | pathogenic | Mucopolysaccharidosis type 6 | 2024-01-24 | criteria provided, single submitter | clinical testing |